期刊
VIRUSES-BASEL
卷 14, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/v14061237
关键词
coronavirus; SARS-CoV-2; ORF8; accessory protein; Fc-mediated effector function; ADCC; monocytes; NK cells; CD16
类别
资金
- le Ministere de l'Economie et de l'Innovation (MEI) du Quebec
- Fondation du CHUM
- CIHR [352417, 177958, OV4-170641]
- CFI [41027]
- Sentinelle COVID Quebec
- Canada Research Chair
- FRQS PhD fellowship
Viruses employ various strategies to evade host immune responses, and SARS-CoV-2 uses Spike mutation and ORF8-mediated reduction of CD16 to escape immunity. ORF8 binds monocytes and NK cells, leading to decreased CD16 levels and impaired cellular cytotoxicity.
Viruses use many different strategies to evade host immune responses. In the case of SARS-CoV-2, its Spike mutates rapidly to escape from neutralizing antibodies. In addition to this strategy, ORF8, a small accessory protein encoded by SARS-CoV-2, helps immune evasion by reducing the susceptibility of SARS-CoV-2-infected cells to the cytotoxic CD8+ T cell response. Interestingly, among all accessory proteins, ORF8 is rapidly evolving and a deletion in this protein has been linked to milder disease. Here, we studied the effect of ORF8 on peripheral blood mononuclear cells (PBMC). Specifically, we found that ORF8 can bind monocytes as well as NK cells. Strikingly, ORF8 binds CD16a (Fc gamma RIIIA) with nanomolar affinity and decreases the overall level of CD16 at the surface of monocytes and, to a lesser extent, NK cells. This decrease significantly reduces the capacity of PBMCs and particularly monocytes to mediate antibody-dependent cellular cytotoxicity (ADCC). Overall, our data identifies a new immune-evasion activity used by SARS-CoV-2 to escape humoral responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据